199 related articles for article (PubMed ID: 11001911)
61. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.
Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M
J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094
[TBL] [Abstract][Full Text] [Related]
62. Multiple regions of ETO cooperate in transcriptional repression.
Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB
J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306
[TBL] [Abstract][Full Text] [Related]
63. The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.
de Laurentiis A; Hiscott J; Alcalay M
Oncogene; 2015 Dec; 34(49):6018-28. PubMed ID: 25893288
[TBL] [Abstract][Full Text] [Related]
64. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
Pine SR; Wiemels JL; Jayabose S; Sandoval C
Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
[TBL] [Abstract][Full Text] [Related]
65. Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia.
Ballerini P; Landman Parker J; Laurendeau I; Olivi M; Vidaud M; Adam M; Leverger G; Gerota I; Cayre YE; Bièche I
Leukemia; 2000 Aug; 14(8):1526-8. PubMed ID: 10942253
[No Abstract] [Full Text] [Related]
66. Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation.
Accordi B; Pillozzi S; Dell'Orto MC; Cazzaniga G; Arcangeli A; Kronnie GT; Basso G
J Biol Chem; 2007 Oct; 282(40):29384-93. PubMed ID: 17673463
[TBL] [Abstract][Full Text] [Related]
67. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
Racanicchi S; Maccherani C; Liberatore C; Billi M; Gelmetti V; Panigada M; Rizzo G; Nervi C; Grignani F
EMBO J; 2005 Mar; 24(6):1232-42. PubMed ID: 15729358
[TBL] [Abstract][Full Text] [Related]
68. Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Pediatric Hematology Working Group in Czech Republic.
Trka J; Zuna J; Hrusák O; Kalinová M; Muzíková K; Lauschman H; Starý J
Leukemia; 1998 Jun; 12(6):996-7. PubMed ID: 9639432
[No Abstract] [Full Text] [Related]
69. TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches.
Loh ML; Rubnitz JE
Curr Opin Hematol; 2002 Jul; 9(4):345-52. PubMed ID: 12042710
[TBL] [Abstract][Full Text] [Related]
70. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
[TBL] [Abstract][Full Text] [Related]
71. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia.
Loh ML; Silverman LB; Young ML; Neuberg D; Golub TR; Sallan SE; Gilliland DG
Blood; 1998 Dec; 92(12):4792-7. PubMed ID: 9845546
[TBL] [Abstract][Full Text] [Related]
72. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
Tiensiwakul P
Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
[TBL] [Abstract][Full Text] [Related]
73. Oligomerization of ETO is obligatory for corepressor interaction.
Zhang J; Hug BA; Huang EY; Chen CW; Gelmetti V; Maccarana M; Minucci S; Pelicci PG; Lazar MA
Mol Cell Biol; 2001 Jan; 21(1):156-63. PubMed ID: 11113190
[TBL] [Abstract][Full Text] [Related]
74. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
Wang L; Hiebert SW
Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
[TBL] [Abstract][Full Text] [Related]
75. [Cytogenetic and FISH findings are complementary in childhood ALL].
Haltrich I; Csóka M; Kovács G; Fekete G
Magy Onkol; 2008 Sep; 52(3):283-91. PubMed ID: 18845499
[TBL] [Abstract][Full Text] [Related]
76. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
[TBL] [Abstract][Full Text] [Related]
77. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
78. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.
Diakos C; Zhong S; Xiao Y; Zhou M; Vasconcelos GM; Krapf G; Yeh RF; Zheng S; Kang M; Wiencke JK; Pombo-de-Oliveira MS; Panzer-Grümayer R; Wiemels JL
Blood; 2010 Dec; 116(23):4885-93. PubMed ID: 20807887
[TBL] [Abstract][Full Text] [Related]
79. Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report.
Park JE; Park IJ; Lim YA; Lee WG; Cho SR
Ann Clin Lab Sci; 2013; 43(2):186-9. PubMed ID: 23694795
[TBL] [Abstract][Full Text] [Related]
80. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
Zent C; Rowley JD; Nucifora G
Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
